In accordance with applicable privacy legislation, the company Kedrion S.p.a., controller of the data acquired via this website, hereby informs the user that said website does not use profiling cookies to send advertising messages tuned to preferences expressed when browsing the internet. This website installs third party cookies. Continuing to browse, including by scrolling down and clicking on website elements, equates to consent.
For more information, also as regards the technical cookies used by the website and to refuse consent to the installation of individual cookies, please refer to the complete cookies disclosure.
You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
-
CORPORATE - 05-11-2018
First Annual International Symposium for the Global Eradication of Rh Disease ends a year of celebrations
The event, supported by Kedrion among others, was held on November 1st at Columbia University in NY
read more -
CORPORATE - 05-09-2018
Kedrion joins Rhesus Solution Initiative (RSI) symposium in Lagos
Nigeria to advocate for Rh Disease universal eradication
read more -
CORPORATE - 16-02-2018
Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017
The prize is awarded to the companies that made the best use of the capital markets
read more -
CORPORATE - 10-01-2018
Hemophilia: Kedrion signs on to groundbreaking PARTNERS programme
Goal is to improve access to replacement therapies for coagulation disorders in Europe
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 